- Home
- TSHA vs AEHR Comparison
TSHA vs AEHR Comparison
Compare TSHA & AEHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- AEHR
- Stock Information
- Founded
- TSHA 2019
- AEHR 1977
- Country
- TSHA United States
- AEHR United States
- Employees
- TSHA N/A
- AEHR N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- AEHR Electrical Products
- Sector
- TSHA Health Care
- AEHR Industrials
- Exchange
- TSHA Nasdaq
- AEHR Nasdaq
- Market Cap
- TSHA 334.1M
- AEHR 370.2M
- IPO Year
- TSHA 2020
- AEHR 1997
- Fundamental
- Price
- TSHA $1.61
- AEHR $11.43
- Analyst Decision
- TSHA Strong Buy
- AEHR Hold
- Analyst Count
- TSHA 8
- AEHR 2
- Target Price
- TSHA $6.63
- AEHR $12.00
- AVG Volume (30 Days)
- TSHA 2.1M
- AEHR 879.1K
- Earning Date
- TSHA 02-26-2025
- AEHR 04-08-2025
- Dividend Yield
- TSHA N/A
- AEHR N/A
- EPS Growth
- TSHA N/A
- AEHR 6.35
- EPS
- TSHA N/A
- AEHR 0.75
- Revenue
- TSHA $9,915,000.00
- AEHR $50,735,000.00
- Revenue This Year
- TSHA N/A
- AEHR $5.83
- Revenue Next Year
- TSHA N/A
- AEHR $23.36
- P/E Ratio
- TSHA N/A
- AEHR $15.18
- Revenue Growth
- TSHA N/A
- AEHR N/A
- 52 Week Low
- TSHA $1.19
- AEHR $9.83
- 52 Week High
- TSHA $4.32
- AEHR $21.44
- Technical
- Relative Strength Index (RSI)
- TSHA 46.14
- AEHR 46.65
- Support Level
- TSHA $1.46
- AEHR $10.60
- Resistance Level
- TSHA $1.76
- AEHR $12.81
- Average True Range (ATR)
- TSHA 0.15
- AEHR 0.59
- MACD
- TSHA 0.01
- AEHR 0.23
- Stochastic Oscillator
- TSHA 39.33
- AEHR 49.82
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About AEHR Aehr Test Systems
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.